Stay updated on Pembrolizumab + Radiation in SCCHN Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.

Latest updates to the Pembrolizumab + Radiation in SCCHN Clinical Trial page
- Check2 days agoChange DetectedThe page revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.2%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check16 days agoChange DetectedThe web page has undergone significant changes, including the addition of specific types of radiotherapy and the facility name, while removing references to certain cancer types and immunological agents.SummaryDifference2%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe page has been updated to version v2.16.11, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1.0%
- Check53 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.2%
Stay in the know with updates to Pembrolizumab + Radiation in SCCHN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.